1 / 6

Focus on Vaccines: Priorities and Responses to Cape Town Recommendations

Focus on Vaccines: Priorities and Responses to Cape Town Recommendations Retooling Task Force Meeting January 15, 2008. Vaccines Focus: Retooling Priorities. In 2008, the Working Group on New TB Vaccines will be initiating efforts to: Evaluate some of the economic aspects of new TB vaccines

xenon
Download Presentation

Focus on Vaccines: Priorities and Responses to Cape Town Recommendations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Focus on Vaccines:Priorities and Responses to Cape Town Recommendations Retooling Task Force MeetingJanuary 15, 2008

  2. Vaccines Focus:Retooling Priorities In 2008, the Working Group on New TB Vaccines will be initiating efforts to: • Evaluate some of the economic aspects of new TB vaccines • Initiate development of target product profiles for new TB vaccines

  3. Cape Town Recommendations Recommendation 2: Share information from technical working groups with programmes and partners. In the next 6 months: • Rewrite, publish and disseminate new brochure on TB vaccines • Request RTF to help fund printing and dissemination In the future: • Develop a website on which this information will be available • Pilot an e-newsletter to update the community on recent developments in TB vaccines • Develop community-based materials regarding TB vaccine development and clinical trials

  4. Cape Town Recommendations Recommendation 5: Consider the role of the business sector • Initial conversations held with Private Sector Constituency Representative to Coordinating Board • Private Sector Constituency Representative is a member of Economics & Product Profiles Task Force

  5. Cape Town Recommendations Recommendation 7: Identify the human resource needs, particularly task-shifting possibilities, that will come with new tools • Too early to determine. Will depend on product profile (ie, pre or post-exposure, delivery mechanism, etc). • Less likely to be a major issue for new vaccines, since plan is to delivery new TB vaccines through existing and future vaccination programmes

  6. Cape Town Recommendations Recommendation 8: Continue to share information on lessons learned from other disease control communities that are engaged in retooling • The Working Group will discuss engagement with other vaccine development groups to understand their retooling experience, processes, successes and lessons learned • Request from RTF: commission development of a “template procedure” for definition of product profiles based on existing experience (ie, pneumococcal conjugate vaccine)

More Related